| 영문 | ovulation cycle | 한글 | 배란주기 |
|---|---|---|---|
| 설명 | 사춘기가 되어 난소가 뇌하수체전엽으로부터의 생식샘자극호르몬의 작용을 받아 원시난포가 발육하고 성숙난포가 된다. 결국에는 난포벽이 파열되어 과립막세포로 둘러싸인 난자가 복강내로 배출된다(배란). 배란 후 24~96시간으로 과립막세포가 비대증식해서 황체를 형성한다. 수정되지 않은 경우 월경황체는 약 10일간 존속하고 퇴행변성해서 백체가 된다. 황체가 퇴행변성하면 다음의 난포가 성숙한다. 난소에서는 이 주기가 반복되고 있다. |
||
| 영문 | reproductive system | 한글 | 생식기계통 |
|---|---|---|---|
| 설명 | 1.남성생식계통: 남성생식기는 정자(sperm)를 생성하는 고환과 정자의 성숙, 운반, 그리고 사정에 관여하는 부고환, 정관, 음경(penis) 등으로 이루어져 있으며, 부속기관으로 외분비샘인 정낭(seminal vesicle), 전립샘(prostate), 요도망물샘(bulbourethral gland, Cowper’s gland) 등을 갖추고 있다. 고환은 정자를 생산하는 생식샘인 동시에 남성호르몬(testosterone)을 분비하는 내분비샘이다. 고환에서 분비되는 남성호르몬은 정자생성과 생식기의 발달 및 유지에 필수적인 역할을 하므로 남성생식기능의 원천은 고환에 있다고 볼 수 있다. 2.여성생식계통: 여성생식기는 난자를 생성하는 난소와 난자를 자궁으로 운반하는 난관, 그리고 자궁과 질로 이루어져 있으며 외분비선인 바르톨린샘를 갖추고 있다. 난소는 난자를 생성하는 생식샘인 동시에 여성호르몬을 분비케하는 내분비샘이다. 월경주기 전반부에 난자를 생성시키기위해 성숙되고 있는 난포에서 분비되는 에스트로겐은 여성 2차 성징의 발달을 관장할 뿐 아니라 자궁내막을 장차 수정될 수정란이 착상하기에 알맞은 상태로 만들어준다. 난자가 분비되고 남은 황체에서 분비되는 푸로게스테론은 자궁내막을 붓도록 하면 분비액을 증가시키며 자궁근의 수축을 방해하여 임신시 임신을 지속시키는 역할을 한다. |
||
| MC | mass casualties; mast cell; Master of Surgery [Lat. Magister Chirurgiae]; maximum concentration; Med... |
|---|---|
| PC | avoirdupois weight [Lat. pondus civile]; packed cells; paper chromatography; paracortex; parent cell... |
| CM | California mastitis [test]; calmodulin; capreomycin; carboxymethyl; cardiac murmur; cardiac muscle; ... |
| ART | absolute retention time; Accredited Record Technician; acoustic reflex test; algebraic reconstructio... |
| DART | developmental and reproductive toxicology |
| ART | Assisted Reproductive Techniques |
|---|---|
| ART | Assisted Reproductive Technologies |
| ARTs | Assisted Reproductive Technologies |
| ART | Assisted Reproductive Technology |
| PRRS | Porcine Reproductive and Respiratory Syndrome |
| reproductive cycle | The cycle which begins with conception and extends through gestation and parturition. (05 Mar 2000) |
|---|---|
| assisted reproductive technology | Originally, a range of techniques for manipulating eggs and sperm in order to overcome infertility. Encompasses drug treatments to stimulate ovulation; surgical methods for removing eggs (e.g., laparoscopy and ultrasound-guided transvaginal aspiration) and for reimplanting embryos (e.g., zygot intrafallopian transfer (or ZIFT); in vitro and in vivo fertilization (e.g., artificial insemination and gamete intrafallopian transfer (or GIFT); ex utero and in utero foetal surgery; as well as laboratory regimes for freezing and screening sperm and embryos, and micromanipulating and cloning embryos. The field's first major success came in 1978 with the birth of "test-tube baby" Louise Brown, engineered by Steptoe, Edwards, et al., of England. As the technologies spread, they increasingly are being employed for purposes beyond infertility, i.e., to reduce the risk of, or avoid passing on, hereditary disease and to select for infant sex. Further uses that would aim at improving the "quality" of offspring have been widely discussed and raise profound legal and ethical questions. See: eugenics. (05 Mar 2000) |
| basic reproductive rate, ratio | <epidemiology> See Reproductive Ratio. (05 Dec 1998) |
| cells, reproductive | The eggs and sperm are the reproductive cells. Each mature reproductive cell is haploid in that it has a single set of 23 chromosomes. (12 Dec 1998) |
| reproductive | Relating to reproduction. (05 Mar 2000) |
| reproductive adaptation | A peculiarity of the reproductive mechanism of a species that results in it being better fitted to its environment (for example, prolonged seed dormancy). (09 Oct 1997) |
| reproductive and urinary physiology | Physiology of the human and animal body, male or female, in the reproductive process and the physiology of the urinary tract. (12 Dec 1998) |
| reproductive assimilation | In sensorimotor theory, an active cognitive process by which past experience is applied to novel situations. (05 Mar 2000) |
| reproductive cells | The eggs and sperm are the reproductive cells. Each mature reproductive cell is haploid in that it has a single set of 23 chromosomes. (12 Dec 1998) |
| reproductive control agents | Substances used either in the prevention or facilitation of pregnancy. (12 Dec 1998) |
| reproductive endocrinologist | An ob-gyn who specialises in the treatment of hormonal disorders that affect reproductive function. (09 Oct 1997) |
| reproductive history | An important aggregate factor in epidemiological studies of women's health. The concept usually includes the number and timing of pregnancies and their outcomes, the incidence of breast feeding, and may include age of menarche and menopause, regularity of menstruation, fertility, gynecological or obstetric problems, or contraceptive usage. (12 Dec 1998) |
| reproductive medicine | A medical-surgical specialty concerned with the morphology, physiology, biochemistry, and pathology of reproduction in man and other animals, and on the biological, medical, and veterinary problems of fertility and lactation. It includes ovulation induction, diagnosis of infertility and recurrent pregnancy loss, and assisted reproductive technologies such as embryo transfer, in vitro fertilization, and intra-fallopian transfer of zygotes. (12 Dec 1998) |
| reproductive nucleus | <cell biology> The smaller nucleus in ciliate protozoans, fully active in inheritance and passed after meiosis to conjugating pairs. Gives rise to the macronucleus or macronuclei. Genes in the micronucleus are not actively transcribed. (18 Nov 1997) |
| reproductive ratio | <epidemiology> 1. Basic reproductive ratio , Ro , a dimensionless parameter which encapsulates the biological details of different transmission mechanisms. For microparasites, Ro , is defined as the average number of secondary cases of infection to which one primary case gives rise throughout its infectious period if introduced into a defined population consisting solely of susceptible individuals. For macroparasites, Ro , is the average number of female offspring (or just offspring in the case of hermaphroditic species) produced throughout the lifetime of a mature female parasite, which themselves achieve reproductive maturity in the absence of density-dependent constraints on the parasite establishment, survival or reproduction. Also known as the basic reproduction rate, number. 2. Effective reproductive ratio , R , The number of secondary cases (microparasites) or female offspring (macroparasites) produced in a host population not consisting entirely of susceptible individuals (microparasites) or within which density dependent constraints limit parasite population growth (macroparasites). Under conditions of stable endemic infection, R=1. (05 Dec 1998) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|